PV Bulletin

New Public Consultations Introduced by the European Medicines Agency

The European Medicines Agency has opened public consultations on the Draft Data Standards Framework as part of its regulatory strategy.

Primary source: View

PV Impact Brief

Urgency: HighConfidence: high

What changed

The EMA established a public consultation period for the Draft EMRN Data Standards Framework, which will enable stakeholders to contribute to the development of data standardisation principles that are vital for regulatory processes.

Why it matters

Engagement in these consultations allows stakeholders to influence regulatory guidance and practices, thereby ensuring that the data standardisation approaches align with industry needs and foster better quality and interoperability of data across the regulatory landscape.

Action needed

Regulatory Intelligence teams should monitor the outcomes of these consultations and update relevant standard operating procedures (SOPs) regarding data governance and reporting, ensuring compliance with new guidelines post-consultation.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 11, 2026

Full briefing

Practical implication

Regulatory Intelligence teams should monitor the outcomes of these consultations and update relevant standard operating procedures (SOPs) regarding data governance and reporting, ensuring compliance with new guidelines post-consultation.

The EMA has initiated a public consultation phase starting from August 17, 2026, to September 18, 2026, involving the Draft EMRN Data Standards Framework. This initiative aims to enhance data standardisation processes within the European medicines regulatory network.

What changed: The EMA established a public consultation period for the Draft EMRN Data Standards Framework, which will enable stakeholders to contribute to the development of data standardisation principles that are vital for regulatory processes.

Why it matters: Engagement in these consultations allows stakeholders to influence regulatory guidance and practices, thereby ensuring that the data standardisation approaches align with industry needs and foster better quality and interoperability of data across the regulatory landscape.

Practical implication: Regulatory Intelligence teams should monitor the outcomes of these consultations and update relevant standard operating procedures (SOPs) regarding data governance and reporting, ensuring compliance with new guidelines post-consultation.

View original source

  • Source: EMA - News
  • Published at source: 2026-09-11T12:00:00.000Z
  • Discovered by monitor: 2026-09-11T21:34:00.295Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicEuropean Medicines Agency · European Union · Updated Sep 10, 2026Translated From French

Veterinary medicinal products containing amoxicillin - referral

Urgency: High

Marketing authorization holders must prepare to submit any relevant pre-clinical and clinical data pertaining to amoxicillin's dosing regimens in pigs during the review.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Sep 10, 2026

Clinical investigation of medicinal products for treatment of migraine - Scientific guideline

Urgency: High

Regulatory teams must integrate the new guidelines into clinical development plans for migraine treatments, particularly focusing on designing studies that consider high placebo response rates in children and the new early intervention protocol.

Country ComplianceLabeling Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Labeling Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicTGA · Australia · Updated Sep 11, 2026

TGA to consult on additional controls for an active sunscreen ingredient

Monitoring

PV teams should prepare for potential updates in SOPs to include new safety evaluation procedures concerning 4-MBC and implement monitoring for consultation outcomes to align compliance and regulatory responses.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 10, 2026

Introduction of Overnight Visitor Levy by Local Leaders in England

Monitoring

Local authorities must conduct public consultations on the levy and submit spending plans by early 2028 as a condition for implementation.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward